Coronary Graft Patency Terminated Phase 4 Trials for Acetylsalicylic acid (DB00945)

IndicationStatusPhase
DBCOND0048067 (Coronary Graft Patency)Terminated4
clinicaltrials.gov IdentifierTitlePurposeDrugs
NCT01158703Aspirin and Plavix Following Coronary Artery Bypass GraftingTreatment